Free Trial

Celadon Pharmaceuticals (CEL) Competitors

Celadon Pharmaceuticals logo
GBX 13.40 0.00 (0.00%)
As of 07/22/2025

CEL vs. CNSL, OTT, BCE, FOX, CZN, CHT, DVW, BRCI, NPT, and RCI

Should you be buying Celadon Pharmaceuticals stock or one of its competitors? The main competitors of Celadon Pharmaceuticals include Cambridge Nutritional Sciences (CNSL), Oxford Technology 3 Venture Capital Trust (OTT), Beacon Energy (BCE), Fox Marble (FOX), Curzon Energy (CZN), 290005 (CHT.L) (CHT), 5008 (DVW.L) (DVW), BlackRock Comms Income Inv Tst (BRCI), NetPlay TV (NPT), and RapidCloud International (RCI). These companies are all part of the "communication" industry.

Celadon Pharmaceuticals vs. Its Competitors

Cambridge Nutritional Sciences (LON:CNSL) and Celadon Pharmaceuticals (LON:CEL) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, media sentiment, valuation, profitability and institutional ownership.

In the previous week, Cambridge Nutritional Sciences' average media sentiment score of 0.00 equaled Celadon Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Cambridge Nutritional Sciences Neutral
Celadon Pharmaceuticals Neutral

Cambridge Nutritional Sciences has a beta of 3.89, suggesting that its share price is 289% more volatile than the S&P 500. Comparatively, Celadon Pharmaceuticals has a beta of -0.26, suggesting that its share price is 126% less volatile than the S&P 500.

Cambridge Nutritional Sciences has a net margin of -3.36% compared to Celadon Pharmaceuticals' net margin of -4,024.62%. Cambridge Nutritional Sciences' return on equity of -3.34% beat Celadon Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Nutritional Sciences-3.36% -3.34% -2.36%
Celadon Pharmaceuticals -4,024.62%-187.26%-34.40%

10.2% of Cambridge Nutritional Sciences shares are held by institutional investors. Comparatively, 10.7% of Celadon Pharmaceuticals shares are held by institutional investors. 10.9% of Cambridge Nutritional Sciences shares are held by insiders. Comparatively, 65.1% of Celadon Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Cambridge Nutritional Sciences has higher revenue and earnings than Celadon Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Nutritional Sciences£9.77M0.86-£3.03MN/AN/A
Celadon Pharmaceuticals£123.38K66.61-£4.97M-£7.98-1.68

Summary

Cambridge Nutritional Sciences beats Celadon Pharmaceuticals on 6 of the 10 factors compared between the two stocks.

Get Celadon Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CEL and its competitors with MarketBeat's FREE daily newsletter.

CEL vs. The Competition

MetricCeladon PharmaceuticalsDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£8.22M£2.19B£5.57B£3.07B
Dividend YieldN/A2.92%4.05%5.02%
P/E Ratio-1.684.2028.09162.65
Price / Sales66.61587.54403.61299,584.54
Price / Cash3.0510.3536.1927.97
Price / Book3.5311.228.604.69
Net Income-£4.97M£21.15B£3.24B£5.90B
7 Day PerformanceN/A1.75%3.53%7.42%
1 Month Performance34.00%7.05%10.99%15.02%
1 Year Performance-78.56%2.65%35.25%80.02%

Celadon Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CEL
Celadon Pharmaceuticals
N/AGBX 13.40
flat
N/AN/A£8.22M£123.38K-1.682,780
CNSL
Cambridge Nutritional Sciences
N/AGBX 3.63
-5.6%
N/A-13.1%£8.65M£9.77M-362.103,200Gap Up
OTT
Oxford Technology 3 Venture Capital Trust
N/AN/AN/AN/A£2.13M-£85K-12.59203Gap Down
BCE
Beacon Energy
N/AGBX 0
flat
N/AN/A£740KN/A-0.3544,600
FOX
Fox Marble
N/AGBX 0.04
-7.0%
N/A-97.1%£167K£722.06K-135.0010,600Gap Down
CZN
Curzon Energy
N/AN/AN/AN/A£34KN/A-3.4014,700Gap Down
CHT
290005 (CHT.L)
N/AN/AN/AN/A£0.00N/A0.0020,300
DVW
5008 (DVW.L)
N/AN/AN/AN/A£0.00N/A0.00N/AGap Up
BRCI
BlackRock Comms Income Inv Tst
N/AN/AN/AN/A£0.00N/A0.00N/AHigh Trading Volume
NPT
NetPlay TV
N/AN/AN/AN/A£0.00N/A0.00147,000
RCI
RapidCloud International
N/AN/AN/AN/A£0.00N/A0.0023,000

Related Companies and Tools


This page (LON:CEL) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners